CORRECTION — Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
LOS ANGELES, May 06, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
Call scheduled for Monday, May 9, 2022 at 10:30 a.m. ETLONDON and REDWOOD CITY, Calif., May 06, 2022 (GLOBE NEWSWIRE)...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...